244 results
8-K
EX-10.1
60ph30 l41psw
6 Mar 24
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
9:23am
8-K
EX-10.3
2tq vyeem6
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
guc9c2y7p1svy
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K/A
EX-10.1
u1b9012 oqg042nloj
2 Feb 24
Departure of Directors or Certain Officers
4:49pm
8-K/A
idn3uapcusgjo3vq9sfo
2 Feb 24
Departure of Directors or Certain Officers
4:49pm
424B5
eap54m8d7sabdzj1
17 Jan 24
Prospectus supplement for primary offering
7:18pm
8-K
EX-99.1
qh5 n4bz4u
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-10.1
y3ws82s wrhg
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-99.1
wj89 7k9iy3weolzha
2 Nov 23
Vaxart Provides Business Update and Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
ktxf20us
6 Sep 23
Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate
4:43pm
8-K
EX-1.1
khkqvtbtt6ao len9ck
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm